The article discusses the rising trend of using prescription diabetes medications like Ozempic and Mounjaro for weight loss, highlighting the ease of access through digital black markets and remote consultations. While these drugs can aid those with obesity, their misuse by individuals seeking quick fixes poses serious health risks and regulatory challenges. Teljes cikk (Euronews.com)